SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership[Amend]
SEC Accession No. 0000899140-07-001800
Filing Date
2007-11-09
Accepted
2007-11-09 17:25:18
Documents
1
Filing Date Changed
2007-11-09
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 9TH AMENDMENT t110907b.txt SC 13D/A 17312
  Complete submission text file 0000899140-07-001800.txt   19496
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43256 | Film No.: 071233033
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A